Dr. Sandberg is a Board Certified ophthalmologist, a Fellow of the American Academy of Ophthalmology and a Fellow of the American College of Surgeons. He is a Voluntary Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami School of Medicine.
Dr. Sandberg was born in New York City. He received his B.A. degree Phi Beta Kappa from Johns Hopkins University, and his M.D. from the Johns Hopkins University School of Medicine, where he was elected to Alpha Omega Alpha, the National Medical Honor Society. He completed his medical internship at New York Hospital, Cornell Medical Center. Dr. Sandberg served two years in the United States Public Health Service doing cancer research at the NIH, then spent a year in Israel establishing a cancer chemotherapy program at Tel Hashomer Hospital. He completed his residency training in Ophthalmology at the Bascom Palmer Eye Institute and has remained active on the voluntary faculty.
Dr. Sandberg has served as President of the Miami Ophthalmologic Society and as Chairman of the Dept. of Ophthalmology of Hollywood Memorial Regional Hospital. He also served on the executive committee of the Florida Society of Ophthalmology and on the board of directors of the Memorial Same Day Surgery Center.
Dr. Sandberg has volunteered for surgical missions to third world countries to train local ophthalmologists in cataract and oculoplastic surgery. He has a particular interest in oculoplastic surgery (functional and cosmetic eyelid surgery, blepharoplasty, ptosis, ectropion, entropion, blocked tear ducts). He has lectured to physicians and community groups, published scientific articles, and participated in research studies on oculoplastic surgery, cataract and intraocular lens surgery, lasers, glaucoma, and the latest treatments for diabetic retinopathy and macula degeneration.
Sandberg, J.S., Brule, S., and Goldin, A. Antileukemic action of a new 4-carbon sugar dimethanesulfonate in mice. Proc. Amer. Assoc. Cancer Res. l0:75, l969.
Pujman, V., Sandberg, J.S., Howsden, L., and Goldin, A. Vliv chlorprothixenu, cytogranu a fluoxidinu na leukemii L1210. IXth Oncologic Conference, Bratislave, Czechoslovakia, October, l969.
Sandberg, J.S., and Goldin, A. Antileukemic action of a new sugar derivative dimethanesulfonate and related compounds in mice. Cancer Chemother. Rep. 53:367-376, l969.
Sandberg, J.S., Howsden, L., DeMarco, A., and Goldin, A. A comparison of the antileukemic effect in mice of adriamycin, a new antitumor antibiotic, with daunomycin. Cancer Chemother. Rep. 54:1-9, l970.
Pujman, V., Sandberg, J.S., Howsden, L., and Goldin, A. Combination chemotherapy of mouse leukemia L1210 with a neuroleptic and antimetabolites. Chemotherapy 15:105-110, 1970.
Sandberg, J.S., and Goldin, A. The use of leucovorin orally in normal and leukemic (L1210) mice to prevent the toxicity and gastrointestinal lesions of high dose methotrexate. Cancer Research. 30:1276-1280, May, l970.
Pujman, V., Sandberg, J., Howsden, L., and Goldin, A. The effect of Fluoxodine on L1210 leukemia in mice. Neoplasma 17,2. 1970.
Sandberg, J.S., and Goldin, A. The use of first generation transplants of a slow-growing solid tumor for the evaluation of new cancer chemotherapeutic agents. Cancer Chemother. Rep. 55:233-238, May, l970.
Sandberg, J.S., Owens, A.H., Jr., and Santos, G.W. Clinical and pathologic characteristics of graft versus host disease produced in cyclophosphamide treated adult mice. J. Natl. Cancer Inst. 46:l5l-160, Jan. l97l.
Goldin, A., Sandberg, J.S., and Henderson, E.S. The chemotherapy of human and animal acute leukemia. Cancer Chemother. Rep. 55:309-505, November, l97l.
Sandberg, J.S., Wood, H.B., Jr., Engle, R.R., Venditti, J.M. and Goldin, A., Methanesulfonates, the relationship of structure to antitumor activity. Cancer Chemother. Rep. (Suppl.) 3:l37-229, Nov. l972.
Sandberg, J.S. and Anderson, D.R. Immunosuppressive agents, Cytosine Arabinoside and Methotrexate by the Sub-Tenon’s route of administration in the treatment of uveitis. Proc. of the Assoc. for Research in Vision and Ophthalmology, p. 28 #ll, l973.
Sandberg, J.S., and Goldhammer, Y. New Observations on Lens Disease. J. Israel Med. Assoc. 87:3l7-3l9, l974.
Sandberg, J.S. Tenth Annual Bascom Palmer Eye Institute Residents Day. Am. J. Ophthal. 78:1034-1040, Dec.1974.
Clayman, H.M., Sandberg, J.S., and Altman, R.D. Ocular Perforation in Pulseless Disease. Neuro- ophthalmology Vol. 8 Glaser and Smith eds. C.V. Mosby; pp. 292-295, l975.
Sandberg, J.S., Our Other Patients Behind the Red Curtin. Miami Medicine, 54: l8-20-, l984.
Sandberg, J.S., Mission Eye Surgery in the Dominican Repbublic, Ocular Surg. News 6(5)16, March 1, 1988.
Rusk, C., Sharpe, E., Laurence, J., Polis, A., Adamsons, I., and the Dorzolamide Comparison Study Group, Comparison of the Efficacy and Safety of 2% Dorzolamide and 0.5% Betaxolol in the Treatment of Elevated Intraocular Pressure – Clinical Therapeutics Vol. 20 No. 3 May-June 1998